Helen Collins

Helen Collins

Chief Tech/Sci/R&D Officer at ENLIVEN THERAPEUTICS, INC.

Net worth: - $ as of 2024-02-28

61 year
Health Technology
Consumer Services
Health Services

Profile

Helen Collins founded North Bay Cancer Alliance, Inc. Currently, Dr. Collins is Chief Medical Officer for Enliven Therapeutics, Inc. Dr. Collins is also on the board of Kura Oncology, Inc. and IO Biotech, Inc. In the past she occupied the position of President of Redwood Regional Medical Group, Inc. and Chief Medical Officer & Executive Vice President at Five Prime Therapeutics, Inc. She received an undergraduate degree from Bryn Mawr College and a doctorate from The Johns Hopkins University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-05-30 0 ( -.--% ) - $ 2024-02-28
2024-02-12 0 ( -.--% ) - $ 2024-02-28

Helen Collins active positions

CompaniesPositionStart
KURA ONCOLOGY, INC. Director/Board Member 2021-07-28
ENLIVEN THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2023-02-22
IO BIOTECH, INC. Director/Board Member 2023-11-08
All active positions of Helen Collins

Former positions of Helen Collins

CompaniesPositionEnd
FIVE PRIME THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2021-04-15
President 2008-12-31
Founder -
See the detail of Helen Collins's experience

Training of Helen Collins

Bryn Mawr College Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Helen Collins's experience

Connections

81

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
KURA ONCOLOGY, INC.

Health Technology

IO BIOTECH, INC.

Health Technology

ENLIVEN THERAPEUTICS, INC.

Health Technology

Private companies3

Health Technology

Health Services

Commercial Services

See company connections
  1. Stock
  2. Insiders
  3. Helen Collins